Continuing our series on Vertical Software (VSaaS), we’re spotlighting the latest sector we’ve been focused on: Autotech. We’ve highlighted before that we believe successful VSaaS companies emerge from fragmented… Read More »Emerging trends in Autotech
Despite pervasive fear, uncertainty and doubt, and rumors of fintech’s demise, we believe that the fintech venture opportunity has never been stronger. It’s a space we know well and… Read More »Unlocking the future of finance: why we are all-in on fintech.
29 September 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Interim results for the six months ended 30 June 2023 Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing… Read More »Interim results for the six months ended 30 June 2023
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing a pipeline of products aimed… Read More »Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement
6 July 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Results of Appeal of Delisting Determination Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing a pipeline of products aimed… Read More »Results of Appeal of Delisting Determination
20 June 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Appeal of Delisting Determination Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing a pipeline of products aimed at primary… Read More »Appeal of Delisting Determination
15 June 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Receipt of NASDAQ Delisting DeterminationPlans to Appeal Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing a pipeline of products… Read More »Receipt of NASDAQ Delisting Determination Plans to Appeal
Bernard Ross, CEO of Sky Medical Technology, explores the role medtech plays in alleviating challenges in wound care to enhance healthcare delivery and ultimately, drive a healthier and more productive population. … Read More »Enhancing standard of wound care with innovative medical technology
A study that aims to deliver a step change in the care of chronic wounds and reduce healthcare costs for wound management has begun patient trials in people with diabetes-related… Read More »Trials begin for wound sensors that may reduce diabetes related amputation
Connect your business with a powerful network of experts, mentors and support services to drive innovation in West Yorkshire. × Expand Connecting Innovation is delivered by the West Yorkshire… Read More »Staying ahead of the curve